EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Arterial Thromboembolism Incidence in Japanese Patients With Lung Cancer

Kazuki Fukuzawa iD, Yoshimitsu Shimomura iD, Ling Zha iD, Haruka Shida, Manabu Hayama, Tetsuhisa Kitamura, Yoshiharu Horie

Cancer Medicine · 2025

DOI: 10.1002/cam4.71356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Kazuki Fukuzawa und 6 weiteren Autor:innen. Beteiligte Einrichtung: Data Science, Medical Division, Osaka, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Thromboembolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with lung cancer tend to have a high incidence of arterial thromboembolism (ATE). However, although ATE is a life‐threatening disease, there are insufficient studies evaluating patient characteristics associated with a high risk of ATE in patients with lung cancer. This study aimed to examine the incidence of ATE in Japanese patients with lung cancer and evaluate the incidence of ATE by histological types and treatment patterns to identify high‐risk groups.

Methods

We conducted a retrospective cohort study using the National Health Insurance (NHI), Employees' Health Insurance (EHI), and Later‐Stage Elderly Healthcare System (LSEHS) claims databases from April 1, 2014, to March 31, 2022. The patients were followed up for up to 5 years after lung cancer diagnosis. The cumulative incidence rates of ATE were calculated, and the histological subtype and treatment pattern were analyzed using the Cox proportional hazards model.

Results

Among 6340 patients in EHI, 10,857 patients in NHI, and 13,039 patients in LSEHS, patient characteristics such as the median age and the prevalence of comorbidities were different among the three databases. The cumulative incidence rates at 1 year were 1.7%, 4.5%, and 7.2%, and those at 5 years were 3.5%, 8.0%, and 15.9%. The adjusted hazard ratio for small cell lung cancer compared to non‐small cell lung cancer was 2.84 (95% confidence interval (CI): 1.46–5.54) in EHI, 0.93 (95% CI: 0.65–1.32) in NHI, and 1.11 (95% CI: 0.85–1.46) in LSEHS. The risk of ATE of RT + systemic therapy and systemic therapy only was higher than surgery only, with a statistically significant difference in the three databases.

Conclusion

In any database, the cumulative incidence of ATE increased over the 5 year observation period. Patients who received RT + systemic therapy and those who received systemic therapy only had a higher risk of ATE than those who underwent surgery only.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsThromboembolismHumansMaleFemaleIncidenceAgedRetrospective StudiesMiddle AgedJapanRisk FactorsAged, 80 and overCarcinoma, Non-Small-Cell LungAdultEast Asian People

Stichwörter der Autor:innen

administrative claimsepidemiologyhealthcareincidencelung neoplasmsthrombosis

Autor:innen und Institutionen

  • Data Science, Medical Division, Osaka, Japan.
  • Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Medical Science Department, Late Development Oncology TA Division, Research & Development, Tokyo, Japan.

ORCID-Profile: Kazuki Fukuzawa, Yoshimitsu Shimomura, Ling Zha

Förderung

  • AstraZeneca

Zitieren

APA

Fukuzawa, K., Shimomura, Y., Zha, L., Shida, H., Hayama, M., Kitamura, T., & Horie, Y. (2025). Arterial Thromboembolism Incidence in Japanese Patients With Lung Cancer. Cancer Medicine. https://doi.org/10.1002/cam4.71356

Vancouver

Fukuzawa K, Shimomura Y, Zha L, Shida H, Hayama M, Kitamura T, et al. Arterial Thromboembolism Incidence in Japanese Patients With Lung Cancer. Cancer Medicine. 2025. doi:10.1002/cam4.71356

BibTeX
@article{Fukuzawa2025,
  author = {Fukuzawa, Kazuki and Shimomura, Yoshimitsu and Zha, Ling and Shida, Haruka and Hayama, Manabu and Kitamura, Tetsuhisa and Horie, Yoshiharu},
  title = {Arterial Thromboembolism Incidence in Japanese Patients With Lung Cancer},
  journal = {Cancer Medicine},
  year = {2025},
  doi = {10.1002/cam4.71356}
}
Kostenlos starten →